563 filings
Page 24 of 29
4
Barrett Peter
27 Jan 16
ZAFGEN / Peter Barrett ownership change
12:00am
4
Cameron Geoffrey McDonough
27 Jan 16
ZAFGEN / Cameron Geoffrey McDonough ownership change
12:00am
4
Booth Bruce
27 Jan 16
ZAFGEN / Bruce Booth ownership change
12:00am
8-K
LRMR
Larimar Therapeutics Inc
20 Jan 16
Zafgen’s Pivotal Phase 3 Trial of Beloranib in Prader-Willi Syndrome Achieves Co-Primary Efficacy Endpoints
12:00am
4
Hughes Thomas E.
8 Jan 16
ZAFGEN / Thomas E. Hughes ownership change
12:00am
SC 13G
Flynn James E
14 Dec 15
Beneficial ownership report
12:00am
8-K
LRMR
Larimar Therapeutics Inc
3 Dec 15
Zafgen Announces Beloranib IND Placed on Complete Clinical Hold
12:00am
8-K
LRMR
Larimar Therapeutics Inc
2 Dec 15
Zafgen Provides Clinical Update on Beloranib
12:00am
SC 13G
Flynn James E
30 Nov 15
Beneficial ownership report
12:00am
10-Q
2015 Q3
LRMR
Larimar Therapeutics Inc
Quarterly report
13 Nov 15
12:00am
8-K
LRMR
Larimar Therapeutics Inc
10 Nov 15
Zafgen Announces Third Quarter 2015 Financial Results
12:00am
4
Perez Robert J
30 Oct 15
ZAFGEN / ROBERT J PEREZ ownership change
12:00am
4
Cameron Geoffrey McDonough
30 Oct 15
ZAFGEN / Cameron Geoffrey McDonough ownership change
12:00am
SC 13G
Foresite Capital Fund II, L.P.
23 Oct 15
Zafgen, Inc.
12:00am
8-K
LRMR
Larimar Therapeutics Inc
22 Oct 15
Zafgen Announces Beloranib Program Update
12:00am
4/A
Dennis D Kim
20 Oct 15
ZAFGEN / DENNIS D KIM ownership change
12:00am
4/A
Dennis D Kim
20 Oct 15
ZAFGEN / DENNIS D KIM ownership change
12:00am
8-K
LRMR
Larimar Therapeutics Inc
16 Oct 15
Zafgen Announces Partial Clinical Hold Affecting Beloranib Trials
12:00am
8-K
LRMR
Larimar Therapeutics Inc
15 Oct 15
Other Events
12:00am
8-K
LRMR
Larimar Therapeutics Inc
30 Sep 15
Zafgen Announces Transition of Board of Directors
12:00am